Navigation Links
MiMedx Announces Record Third Quarter Results
Date:10/30/2013

MARIETTA, Ga., Oct. 30, 2013 /PRNewswire/ -- MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended September 30, 2013.

Highlights of third quarter of 2013 results include:

  • Revenue exceeds high end of guidance (8th consecutive quarter of meeting or exceeding upper end of guidance)
  • Revenue increased more than 100% over third quarter of 2012
  • Nine-month revenue increased nearly 150% over same period of 2012
  • 7th consecutive quarter of positive Adjusted EBITDA
  • Quarterly Cash Flow from Operations Positive for the First time in Company History
  • Company reiterates increased lower end of 2013 full year revenue guidance
  • Third Quarter 2013 Results
    The Company recorded record revenue for the quarter ended September 30, 2013, with revenue of $16.1 million, an increase of more than 100% over third quarter of 2012 revenue of $8.0 million. The Company's third quarter gross margins were 87% as compared to gross margins of 82% in the third quarter of last year.  Earnings before interest, taxes, depreciation, amortization and share based compensation (Adjusted EBITDA*) for the third quarter of 2013 were $1.9 million, a $1.1 million  or  156% improvement, as compared to the Adjusted EBITDA of $726,000 for the third quarter of 2012. The Net Loss for the third quarter of 2013 was $307,000 as compared to net loss of $4.2 million in the prior year third quarter. The prior year Net Loss included a $1.8 million Intangible Asset impairment charge and a $1.3 million charge related to the fair value adjustment of the earn-out liability related to the acquisition of Surgical Biologics. 

    <
    '/>"/>
    SOURCE MiMedx
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. MiMedx Reports On Meeting With FDA
    2. MiMedx Responds To Misleading And Inaccurate Media Reports
    3. MiMedx Plantar Fasciitis Study Published In The Foot & Ankle International Journal
    4. MiMedx To Present At 33rd Annual Canaccord Genuity Growth Conference
    5. Mimedx Scientific Study Is Electronically Published in The International Wound Journal
    6. MiMedx Announces Record Second Quarter Results
    7. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
    8. MiMedx To Exceed High End Of Second Quarter Guidance
    9. MiMedx to Ring NASDAQ Stock Market Opening Bell
    10. MiMedx to Present at Jefferies 2013 Global Healthcare Conference
    11. MiMedx Secures a $3.0 Million Revolving Line of Credit with Bank of America
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/21/2015)... May 21, 2015 Specialty Pharmacy ... and been admitted to BPA Worldwide as a ... will track audience data for Specialty Pharmacy Times ... , “By becoming a member of BPA Worldwide, ... providing our clients with the most reliable, unequaled ...
    (Date:5/21/2015)... -- Prima Biomed Ltd. (NASDAQ: PBMD ) a globally ... leader in the development of immunotherapeutic products for the ... data from the Phase II CAN-003 ovarian cancer clinical ... meaningful improvement in Overall Survival ("OS") over standard of ... the group of second remission patients (n=20), the median ...
    (Date:5/21/2015)... , May 21, 2015  The EveryLife Foundation ... (R-UT) and Amy Klobuchar (D-MN) ... Accelerating Cures & Treatments, or OPEN ACT. ... patient advocacy organizations, this bipartisan legislation promises to ... medicines to rare disease patients by incentivizing drug ...
    (Date:5/21/2015)... 21, 2015 W. R. Grace ... facility in Worms, Germany has received good manufacturing ... of the International Pharmaceutical Excipient Council (IPEC) Foundation. ... produce its SYLOID® FP brand of pharmaceutical grade ... following the Curtis Bay, Maryland (USA) and Sorocaba, ...
    Breaking Biology Technology:Specialty Pharmacy Times Joins BPA Worldwide 2Correction Continues after Big Move - BrokerBank Securities, Inc. 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2
    ... When it comes to the health of their,children and even parents, ... about health and medicine. With the many different,medicines out there, it ... taking,what and the dangers of drug reactions, interactions and side effects. ... ) , In fact, the ...
    ... Institute of Bioengineering and Nanotechnology (IBN) have uncovered new ... could play a vital role in disease prevention and ... of IMSs was published in the Journal of ... study published in Angewandte Chemie International Edition , ...
    ... is proud to announce,it has earned the highly valued ... Care Organizations (JCAHO) by demonstrating compliance,with national standards for ... "In becoming accredited, SleepQuest was evaluated ... home care service survey team,",says Debra Zak, Ph.D., RN, ...
    Cached Biology Technology:Family Medicine Cabinet: Free, New On-Line Tool Helps Track Your Medication Safety 2New uses for imidazolium salts in medicine and alternative energy 2New uses for imidazolium salts in medicine and alternative energy 3SleepQuest Achieves Coveted Accreditation 2
    (Date:4/8/2015)... CHARLOTTE, N.C. , April 8, 2015 /PRNewswire/ ... technology solutions and services, and Morpho, a leading ... in partnership to produce the market,s most advanced ... Infinisource,s iSolved NXG time clock is setting ... attendance and labor data for the small and ...
    (Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
    (Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
    Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2
    ... mild coastal climate of western Washington, agricultural growers are ... vegetables in high tunnel production systems. High tunnels can ... from environmental stresses such as hail, frost, excessive rainfall, ... of high tunnels for growing both lettuce and tomato ...
    ... of Allergy and Infectious Diseases (NIAID) has awarded the ... study genes of unknown function in bacteria that cause ... of biochemistry and molecular biophysics will lead the effort ... as yet have no defined functional roleas part of ...
    ... Texas Heart Institute have discovered a new way to dramatically ... this knowledge to combat human cardiovascular disease by improving repair ... in the scientific journal Development . Professor James ... the Hippo pathway, that normally blocks heart repair in adult ...
    Cached Biology News:High tunnel, open-field production systems compared for lettuce, tomato 2Study to identify functions of hypothetical genes in 2 infectious disease pathogens 2Breakthrough in adult heart repair 2
    4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to SGG (Sheep gamma globulin) lysine through amide bonds. This product is homologous to NP-BSA....
    ... Fiberboard boxes are ideal for use in refrigerators, freezers, ... racks. Four vibrant colors allow for color coding to ... liquid nitrogen drainage or promote cool air circulation. Supplied ... holds 81 tubes. Box dimensions: 13 x ...
    RABBIT ANTI BACTERIAL HISTIDASE...
    2,4-Dinitrophenyl hapten is conjugated to BSA (Bovine Serum Albumin) protein through lysine....
    Biology Products: